The enduring success of sildenafil has undeniably shaped the healthcare landscape. However, investing in companies heavily dependent on biosimilars and the waning patent rights surrounding this iconic https://aronvlfb101211.oblogation.com/39859394/sildenafil-and-drugmakers-a-risky-venture